BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin X, Chen W, Xie Q, Yu Y, Liao Y, Feng Z, Qin X, Wu X, Tang S, Zheng H. Dissemination and genome analysis of high-level ceftriaxone-resistant penA 60.001 Neisseria gonorrhoeae strains from the Guangdong Gonococcal Antibiotics Susceptibility Programme (GD-GASP), 2016-2019. Emerg Microbes Infect 2022;:1-19. [PMID: 34994305 DOI: 10.1080/22221751.2021.2011618] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Shimuta K, Takahashi H, Akeda Y, Nakayama SI, Ohnishi M. Loop-Mediated Isothermal Amplification Assay for Identifying Neisseria gonorrhoeae Nonmosaic penA-Targeting Strains Potentially Eradicable by Cefixime. Microbiol Spectr 2022;:e0233522. [PMID: 36000906 DOI: 10.1128/spectrum.02335-22] [Reference Citation Analysis]
2 Yang F, Gao S, Yan J, Lin X, van der Veen S. Moenomycin is broadly active against multidrug-resistant Neisseria gonorrhoeae and clears an infection from a murine vaginal tract infection model. J Antimicrob Chemother 2022:dkac202. [PMID: 35762496 DOI: 10.1093/jac/dkac202] [Reference Citation Analysis]
3 Lin X, Qin X, Wu X, Liao Y, Yu Y, Xie Q, Tang S, Guo C, Pei J, Wu Z, Cai C, Wang F, Wu S, Chen H, Liu X, Li M, Cao W, Zheng H. Markedly Increasing Antibiotic Resistance and Dual Treatment of Neisseria gonorrhoeae Isolates in Guangdong, China, from 2013 to 2020. Antimicrob Agents Chemother 2022;:e0229421. [PMID: 35345891 DOI: 10.1128/aac.02294-21] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Scurtu LG, Jinga V, Simionescu O. Fascinating Molecular and Immune Escape Mechanisms in the Treatment of STIs (Syphilis, Gonorrhea, Chlamydia, and Herpes Simplex). Int J Mol Sci 2022;23:3550. [PMID: 35408911 DOI: 10.3390/ijms23073550] [Reference Citation Analysis]